Japan‘s Shionogi & Co. Ltd announced on Monday that phase III of its clinical trial for a new COVID-19 vaccine has begun in Vietnam.
The pharmaceutical company has already conducted clinical trials in Japan, but had said previously they will conduct multiple trials globally as well.
(Reporting by Sakura Murakami; Editing by Shri Navaratnam)
Follow Canada News Media
Get the day's top Canadian stories and our two daily 60-second news videos wherever you scroll.
X Threads Facebook Instagram LinkedIn TikTok YouTube Pinterest Reddit Substack Flipboard Newsletter RSS
